Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Afeyan Noubar Newcogen Long Reign Holding Llc

Affiliations

  • Large Shareholder at Transmedics Group Inc. (TMDX), 2019-10-31
  • Large Shareholder, Director at Moderna Inc. (MRNA), 2019-06-28
  • Large Shareholder, Director at Seres Therapeutics Inc. (MCRB), 2019-06-20
  • Large Shareholder, Director at Evelo Biosciences Inc. (EVLO), 2019-06-13
  • Large Shareholder, Director at Rubius Therapeutics Inc. (RUBY), 2019-05-29
  • Large Shareholder at Axcella Health Inc. (AXLA), 2019-05-15
  • Large Shareholder, Director at Kaleido Biosciences Inc. (KLDO), 2019-03-06
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2018-02-13
  • Large Shareholder at Quanterix Corp (QTRX), 2017-12-13
  • Large Shareholder at Denali Therapeutics Inc. (DNLI), 2017-12-12
  • Large Shareholder at Eleven Biotherapeutics Inc. (EBIO), 2016-09-26
  • Large Shareholder at Editas Medicine Inc. (EDIT), 2016-08-15
  • Large Shareholder at Selecta Biosciences Inc (SELB), 2016-06-29
  • Large Shareholder, Director at Bg Medicine Inc. (BGMD), 2015-12-11
  • Large Shareholder at T2 Biosystems Inc. (TTOO), 2014-08-14
  • Large Shareholder at Agios Pharmaceuticals Inc (AGIO), 2014-06-25
  • Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2014-02-19
  • Large Shareholder at Receptos Inc. (RCPT), 2013-11-19
  • Large Shareholder, Director at Bind Therapeutics Inc (BIND), 2013-09-27
  • Large Shareholder at Acceleron Pharma Inc (XLRN), 2013-09-19
  • Large Shareholder at Tetraphase Pharmaceuticals Inc (TTPH), 2013-03-28
  • Large Shareholder, Director at Helicos Biosciences Corp (HLCS), 2009-10-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MCRB $2.25 4,444,444 Large Shareholder, Director 4,444,444 2019-06-18 Filing
MCRB $2.25 4,444,444 Large Shareholder, Director 4,444,444 2019-06-18 Filing
BIND $15.00 20,000 Large Shareholder, Director 1,562,616 2013-09-25 Filing
BGMD $2.00 1,050,000 Large Shareholder, Director 1,764,286 2013-01-30 Filing
BGMD $2.00 500,000 Large Shareholder, Director 2,851,447 2013-01-30 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MCRB $27.60 599,297 Large Shareholder, Director 0 2016-05-25 Filing
MCRB $27.60 80,141 Large Shareholder, Director 1,925,462 2016-05-25 Filing
MCRB $27.60 320,562 Large Shareholder, Director 2,734,994 2016-05-25 Filing
BGMD $0.56 2,508 Large Shareholder, Director 0 2015-12-09 Filing
BGMD $0.56 43,930 Large Shareholder, Director 0 2015-12-09 Filing